Log in

NASDAQ:VCYTVeracyte News Headlines

$31.76
-0.44 (-1.37 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$29.65
Now: $31.76
$32.18
50-Day Range
$23.06
MA: $28.75
$35.67
52-Week Range
$13.90
Now: $31.76
$36.42
Volume4.36 million shs
Average Volume530,849 shs
Market Capitalization$1.61 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.97

Headlines

Veracyte (NASDAQ VCYT) News Headlines

Source:
DateHeadline
Veracyte (NASDAQ:VCYT) Price Target Raised to $40.00Veracyte (NASDAQ:VCYT) Price Target Raised to $40.00
marketbeat.com - July 31 at 11:26 AM
Short Interest in Veracyte Inc (NASDAQ:VCYT) Expands By 12.1%Short Interest in Veracyte Inc (NASDAQ:VCYT) Expands By 12.1%
americanbankingnews.com - August 6 at 2:22 AM
Veracyte prices equity offering at $30 - Seeking AlphaVeracyte prices equity offering at $30 - Seeking Alpha
seekingalpha.com - August 5 at 11:58 PM
Veracyte (NASDAQ:VCYT) Shares Gap Down  Following Insider SellingVeracyte (NASDAQ:VCYT) Shares Gap Down Following Insider Selling
americanbankingnews.com - August 5 at 7:30 PM
Veracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung Diseases - Business WireVeracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung Diseases - Business Wire
businesswire.com - August 5 at 6:56 PM
Scaling Up Output of a Covid Vaccine Is Costly, Says ModernaScaling Up Output of a Covid Vaccine Is Costly, Says Moderna
finance.yahoo.com - August 5 at 6:56 PM
Veracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung DiseasesVeracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung Diseases
finance.yahoo.com - August 5 at 6:56 PM
Veracyte Announces Positive Clinical Utility Data for Percepta Classifier Published in CHEST - Business WireVeracyte Announces Positive Clinical Utility Data for Percepta Classifier Published in CHEST - Business Wire
businesswire.com - August 5 at 8:55 AM
Veracyte Announces Positive Clinical Utility Data for Percepta Classifier Published in CHESTVeracyte Announces Positive Clinical Utility Data for Percepta Classifier Published in CHEST
finance.yahoo.com - August 5 at 8:55 AM
Veracyte Inc (NASDAQ:VCYT) Director Sells $713,400.00 in StockVeracyte Inc (NASDAQ:VCYT) Director Sells $713,400.00 in Stock
americanbankingnews.com - August 5 at 5:10 AM
Evan/ Fa Jones Sells 20,000 Shares of Veracyte Inc (NASDAQ:VCYT) StockEvan/ Fa Jones Sells 20,000 Shares of Veracyte Inc (NASDAQ:VCYT) Stock
americanbankingnews.com - August 5 at 5:10 AM
-$0.12 Earnings Per Share Expected for Veracyte Inc (NASDAQ:VCYT) This Quarter-$0.12 Earnings Per Share Expected for Veracyte Inc (NASDAQ:VCYT) This Quarter
americanbankingnews.com - August 5 at 2:12 AM
Veracyte Announces Pricing of Public Offering of 6000000 Shares of Common Stock - Business WireVeracyte Announces Pricing of Public Offering of 6000000 Shares of Common Stock - Business Wire
businesswire.com - August 4 at 10:54 PM
Investors Buy Large Volume of Veracyte Call Options (NASDAQ:VCYT)Investors Buy Large Volume of Veracyte Call Options (NASDAQ:VCYT)
americanbankingnews.com - August 4 at 9:38 PM
Veracyte (NASDAQ:VCYT) Stock Price Down 8.8%Veracyte (NASDAQ:VCYT) Stock Price Down 8.8%
americanbankingnews.com - August 4 at 8:35 PM
Veracyte launches 6M-share stock offering - Seeking AlphaVeracyte launches 6M-share stock offering - Seeking Alpha
seekingalpha.com - August 3 at 4:50 PM
Veracyte Announces Proposed Public Offering of Common Stock - Business WireVeracyte Announces Proposed Public Offering of Common Stock - Business Wire
businesswire.com - August 3 at 4:50 PM
Veracyte Announces Proposed Public Offering of Common StockVeracyte Announces Proposed Public Offering of Common Stock
finance.yahoo.com - August 3 at 4:50 PM
Veracyte, Inc. (VCYT) CEO Bonnie Anderson on Q2 2020 Results - Earnings Call Transcript - Seeking AlphaVeracyte, Inc. (VCYT) CEO Bonnie Anderson on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 3 at 6:50 AM
What Can We Learn About Veracytes (NASDAQ:VCYT) CEO Compensation? - Yahoo FinanceWhat Can We Learn About Veracyte's (NASDAQ:VCYT) CEO Compensation? - Yahoo Finance
finance.yahoo.com - August 2 at 12:44 PM
What Can We Learn About Veracyte's (NASDAQ:VCYT) CEO Compensation?What Can We Learn About Veracyte's (NASDAQ:VCYT) CEO Compensation?
finance.yahoo.com - August 2 at 12:44 PM
Short Interest in Veracyte Inc (NASDAQ:VCYT) Increases By 12.1%Short Interest in Veracyte Inc (NASDAQ:VCYT) Increases By 12.1%
www.americanbankingnews.com - August 1 at 4:18 AM
Veracyte EPS beats by $0.05, beats on revenue - Seeking AlphaVeracyte EPS beats by $0.05, beats on revenue - Seeking Alpha
seekingalpha.com - July 31 at 1:40 PM
Veracyte (NASDAQ:VCYT) Given New $40.00 Price Target at Lake Street CapitalVeracyte (NASDAQ:VCYT) Given New $40.00 Price Target at Lake Street Capital
www.americanbankingnews.com - July 31 at 1:04 PM
Veracyte (NASDAQ:VCYT) Price Target Increased to $37.00 by Analysts at SVB LeerinkVeracyte (NASDAQ:VCYT) Price Target Increased to $37.00 by Analysts at SVB Leerink
www.americanbankingnews.com - July 31 at 12:06 PM
Veracyte (NASDAQ:VCYT) Price Target Raised to $37.00 at Needham & Company LLCVeracyte (NASDAQ:VCYT) Price Target Raised to $37.00 at Needham & Company LLC
www.americanbankingnews.com - July 31 at 10:57 AM
Veracyte : MAVIDx To Develop COVID-19 Testing On NCounter SystemVeracyte : MAVIDx To Develop COVID-19 Testing On NCounter System
www.nasdaq.com - July 31 at 7:39 AM
Veracyte partners with MAVIDx for COVID-19 diagnostic kitsVeracyte partners with MAVIDx for COVID-19 diagnostic kits
seekingalpha.com - July 31 at 7:39 AM
Veracyte (VCYT) Tops Q2 EPS by 2c - StreetInsider.comVeracyte (VCYT) Tops Q2 EPS by 2c - StreetInsider.com
www.streetinsider.com - July 30 at 8:29 PM
Veracyte Announces Second Quarter 2020 Financial Results - Business WireVeracyte Announces Second Quarter 2020 Financial Results - Business Wire
www.businesswire.com - July 30 at 8:29 PM
Veracyte (NASDAQ:VCYT) Reaches New 1-Year High at $33.03Veracyte (NASDAQ:VCYT) Reaches New 1-Year High at $33.03
www.americanbankingnews.com - July 30 at 4:46 PM
Veracyte Announces Data Published in AJRCCM Showing That the Envisia Genomic Classifier Improves Physicians Ability to Diagnose IPF Without Surgery - Business WireVeracyte Announces Data Published in AJRCCM Showing That the Envisia Genomic Classifier Improves Physicians' Ability to Diagnose IPF Without Surgery - Business Wire
www.businesswire.com - July 30 at 3:28 PM
Veracyte Announces Data Published in AJRCCM Showing That the Envisia Genomic Classifier Improves Physicians’ Ability to Diagnose IPF Without SurgeryVeracyte Announces Data Published in AJRCCM Showing That the Envisia Genomic Classifier Improves Physicians’ Ability to Diagnose IPF Without Surgery
finance.yahoo.com - July 30 at 10:27 AM
Veracyte (NASDAQ:VCYT) Stock Price Up 6.2%Veracyte (NASDAQ:VCYT) Stock Price Up 6.2%
www.americanbankingnews.com - July 29 at 8:17 PM
Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System - Business WireVeracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System - Business Wire
www.businesswire.com - July 29 at 12:37 PM
Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter SystemVeracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
finance.yahoo.com - July 29 at 12:37 PM
Analysts Estimate Veracyte (VCYT) to Report a Decline in Earnings: What to Look Out for - Yahoo FinanceAnalysts Estimate Veracyte (VCYT) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
finance.yahoo.com - July 24 at 7:40 AM
Analysts Estimate Veracyte (VCYT) to Report a Decline in Earnings: What to Look Out for - NasdaqAnalysts Estimate Veracyte (VCYT) to Report a Decline in Earnings: What to Look Out for - Nasdaq
www.nasdaq.com - July 23 at 3:49 PM
Analysts Estimate Veracyte (VCYT) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Veracyte (VCYT) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - July 23 at 3:49 PM
Veracyte (VCYT) Set to Announce Earnings on ThursdayVeracyte (VCYT) Set to Announce Earnings on Thursday
www.americanbankingnews.com - July 23 at 3:40 AM
The Daily Biotech Pulse: Aurinias Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgicals Q2 Beat - BenzingaThe Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat - Benzinga
www.benzinga.com - July 22 at 8:04 AM
Veracyte Clears Technical Benchmark, Hitting 80-Plus RS RatingVeracyte Clears Technical Benchmark, Hitting 80-Plus RS Rating
finance.yahoo.com - July 16 at 7:56 PM
Veracyte to Release Second Quarter 2020 Financial Results on July 30, 2020 - Yahoo FinanceVeracyte to Release Second Quarter 2020 Financial Results on July 30, 2020 - Yahoo Finance
finance.yahoo.com - July 16 at 9:55 AM
Veracyte to Release Second Quarter 2020 Financial Results on July 30, 2020Veracyte to Release Second Quarter 2020 Financial Results on July 30, 2020
finance.yahoo.com - July 16 at 9:55 AM
Veracyte Inc (NASDAQ:VCYT) Receives Consensus Rating of "Buy" from AnalystsVeracyte Inc (NASDAQ:VCYT) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - July 16 at 1:21 AM
$17.56 Million in Sales Expected for Veracyte Inc (NASDAQ:VCYT) This Quarter$17.56 Million in Sales Expected for Veracyte Inc (NASDAQ:VCYT) This Quarter
www.americanbankingnews.com - July 15 at 8:23 PM
Giulia C. Kennedy Sells 16,738 Shares of Veracyte Inc (NASDAQ:VCYT) StockGiulia C. Kennedy Sells 16,738 Shares of Veracyte Inc (NASDAQ:VCYT) Stock
www.americanbankingnews.com - July 15 at 12:42 AM
-$0.22 Earnings Per Share Expected for Veracyte Inc (NASDAQ:VCYT) This Quarter-$0.22 Earnings Per Share Expected for Veracyte Inc (NASDAQ:VCYT) This Quarter
www.americanbankingnews.com - July 13 at 3:16 AM
Is Veracyte Inc (VCYT) A Good Stock To Buy? - Yahoo FinanceIs Veracyte Inc (VCYT) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - July 5 at 5:44 PM
Is Veracyte Inc (VCYT) A Good Stock To Buy?Is Veracyte Inc (VCYT) A Good Stock To Buy?
finance.yahoo.com - July 5 at 5:43 PM
The Math Shows IEHS Can Go To $34 - NasdaqThe Math Shows IEHS Can Go To $34 - Nasdaq
www.nasdaq.com - June 26 at 11:54 AM
This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.